Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

GlaxoSmithKline Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 55936.18 P/BV 33.44 Book Value ( ₹ ) 98.74
52 Week High/Low ( ₹ ) 3516/1921 FV/ML 10/1 P/E(X) 60.13
Book Closure 30/05/2025 EPS ( ₹ ) 54.91 Div Yield (%) 1.64
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]3726.033441.773226.383264.082895.75
Other Operating Revenues23.1811.9425.3413.9529.86
Total Operating Revenues3749.213453.713251.723278.032925.60
      
Other Income145.93122.59100.6675.78110.58
Total Revenue3895.143576.303352.383353.803036.18
      
EXPENSES     
Cost Of Materials Consumed499.90545.17427.49611.18471.78
Purchase Of Stock-In Trade845.11853.08788.43729.44823.09
Operating And Direct Expenses0.000.0073.850.000.00
Changes In Inventories Of FG,WIP And Stock-In Trade45.85-63.7268.9615.57-38.02
Employee Benefit Expenses579.70624.39594.99610.23616.16
Finance Costs1.311.801.812.003.53
Depreciation And Amortisation Expenses66.7969.6865.7768.1978.60
Other Expenses601.29586.10493.73549.73454.45
Total Expenses2639.952616.502515.022586.332409.60
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1255.19959.80837.37767.47626.59
      
Exceptional Items4.69-143.62-0.9711.58-172.60
Profit/Loss Before Tax1259.88816.19836.40779.05453.99
      
Tax Expenses-Continued Operations     
Current Tax325.96237.59247.13219.74158.67
Deferred Tax6.34-11.36-18.37-9.408.05
Tax For Earlier Years0.000.000.00187.940.00
Total Tax Expenses332.30226.23228.76398.28166.72
Profit/Loss After Tax And Before ExtraOrdinary Items927.58589.96607.64380.77287.27
      
Profit/Loss From Continuing Operations927.58589.96607.64380.77287.27
      
Profit/Loss From Discontinuing Operations0.000.004.131708.1896.51
Total Tax Expenses Discontinuing Operations0.000.001.08394.2325.63
Net Profit/Loss From Discontinuing Operations0.000.003.041313.9570.88
Profit/Loss For The Period927.58589.96610.691694.72358.15
      
Minority Interest2.664.176.040.000.00
Consolidated Profit/Loss After MI And Associates930.24594.13616.721694.72358.15
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)54.5241.1436.0899.2931.35
Diluted EPS (Rs.)54.7634.8336.05100.0421.14
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend745.39542.101524.66508.22677.62
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]3726.03
Other Operating Revenues23.18
Total Operating Revenues3749.21
Other Income145.93
Total Revenue3895.14
EXPENSES 
Cost Of Materials Consumed499.90
Purchase Of Stock-In Trade845.11
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade45.85
Employee Benefit Expenses579.70
Finance Costs1.31
Depreciation And Amortisation Expenses66.79
Other Expenses601.29
Total Expenses2639.95
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1255.19
Exceptional Items4.69
Profit/Loss Before Tax1259.88
Tax Expenses-Continued Operations 
Current Tax325.96
Deferred Tax6.34
Tax For Earlier Years0.00
Total Tax Expenses332.30
Profit/Loss After Tax And Before ExtraOrdinary Items927.58
Profit/Loss From Continuing Operations927.58
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period927.58
Minority Interest2.66
Consolidated Profit/Loss After MI And Associates930.24
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)54.52
Diluted EPS (Rs.)54.76
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend745.39